We Can Medicines Revenue

In the year 2025, We Can Medicines had annual revenue of 3.22B TWD, down -1.45%. We Can Medicines had revenue of 817.54M in the quarter ending December 31, 2025, with 0.36% growth.

Revenue

3.22B

Revenue Growth

-1.45%

P/S Ratio

0.38

Revenue / Employee

3.21M

Employees

1,005

Market Cap

1.22B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.22B	-47.40M	-1.45%
Dec 31, 2024	3.27B	146.31M	4.69%
Dec 31, 2023	3.12B	-179.84M	-5.45%
Dec 31, 2022	3.30B	508.66M	18.21%
Dec 31, 2021	2.79B	127.32M	4.77%
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
DaBomb Protein Biotech	309.34M
Jia Jie Biomedical	485.40M
Lian Fa International Dining Business	1.17B
Wonder Pets Enterprises	3.21B
Tai Roun Products	3.33B
Hantech Bio-Technology	778.54M
Ten Ren Tea	2.16B
SunWay Biotech Co., LTD.	951.52M

Revenue Rankings